The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose-escalation and pharmacokinetic study of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin at the time of primary cytoreductive surgery for advanced ovarian, fallopian tube, and peritoneal carcinomas.
 
Leslie M. Randall
Consulting or Advisory Role - Genentech/Roche
Speakers' Bureau - Sanofi
Research Funding - Array BioPharma (Inst); Astellas Pharma (Inst); Genentech/Roche (Inst); On Target Laboratories (Inst)
 
Dan Gillen
No Relationships to Disclose
 
Fong Wu Liu
No Relationships to Disclose
 
Krishnansu Sujata Tewari
Honoraria - Advaxis; Caris Life Sciences; Genentech/Roche
Speakers' Bureau - Caris Life Sciences
Research Funding - Aeterna Zentaris (Inst); Amgen (Inst); Endocyte (Inst); Genentech/Roche (Inst)
 
Ramez Hassef Eskander
Speakers' Bureau - Genentech/Roche
 
Kristine Renee Penner
No Relationships to Disclose
 
Robert Bristow
No Relationships to Disclose